Posts Tagged ‘THLD’

WTW big gains, MSFT heavy volume, THLD takes profits

Thursday, February 17th, 2011

Weight Watchers International Inc. (NYSE: WTW) shares surged 41% to $63.32. Share volume was 7.5 million shares, dwarfing its daily average of 303,000, after fourth-quarter earnings more than doubled.

Microsoft Corporation (Nasdaq: MSFT) dealt in 37.5 million shares Thursday, catching up on its daily average of 57.2 million, MSFT prices improved 0.8% to $27.23.

Threshold Pharmaceuticals Inc. (Nasdaq: THLD) gave back 14.9% in price Thursday to $2.34. Volume was 3.9 million shares, nearly 10 times its daily average, after agreeing with the FDA on a Special Protocol Assessment for a Phase 3 randomized trial of TH-302 in patients with soft tissue sarcoma.

Tags: , , , , , , ,
Posted in Consumer Discretionary Stocks, Health Care Stocks, Technology Stocks | No Comments »

THLD breaks down door, INTC active, DRWI scorched

Thursday, January 13th, 2011

Threshold Pharmaceuticals Inc. (Nasdaq: THLD) shares gained 16.9 percent to $2.01 Thursday. Volume was 606,335, triple its full-day volume average. THLD is a biotechnology company focused on the discovery and development of drugs targeting Tumor Hypoxia, the low oxygen condition found in microenvironments of most solid tumors.

Intel Corporation (Nasdaq: INTC) traded in 47,608,915 shares Thursday, catching up to its daily average of 55,807,500. Prices for the chip maker were off 0.3 percent to $21.24.

DragonWave Inc. (Nasdaq: DRWI) fell 15.4 percent Thursday to $7.33 Volume for the stock was 3,399,796 shares proved nearly seven times its full-day average. Wednesday, the Ottawa-based DRWI announced quarterly figures showing revenue of $27.0 million, compared with $51.6 million in the third quarter of fiscal year 2010. Net loss in the third quarter of fiscal year 2011 was $0.05 million, compared to net income of $11.6 million in the prior-year quarter.

Tags: , , , , , , ,
Posted in Health Care Stocks, Technology Stocks | No Comments »

THLD soars, C sells, ISPH stumbles

Monday, January 3rd, 2011

Threshold Pharmaceuticals Inc. (Nasdaq: THLD) started 2011 higher 34.08 percent in price Monday to $1.81. Volume of 49,432 shares closed in on its all-day average of 94,631. THLD, based in Redwood City, Calif., Threshold is a biotechnology company focused on the discovery and development of drugs targeting Tumor Hypoxia, the low oxygen condition found in microenvironments of most solid tumors.

Citigroup Inc. (NYSE: C) did a brisk business the first Monday after New Year, trading in 43,054,072 shares, making up ground on its daily average of 538,216,000. Prices for the stock pushed ahead 1.8 percent to $4.82, on announcing that on New Year’s Eve, C it had completed transactions with Discover Financial Services and SLM Corporation that resulted in the divestiture of its student loan business, The Student Loan Corporation.

Inspire Pharmaceuticals Inc. (Nasdaq: ISPH) listed downward Monday, losing 58.45 percent in price to $3.49, on volume of 6,848,880 shares, dwarfing a full-day average of 577,058. ISPH announced today the top-line results from its second Phase 3 clinical trial, TIGER-2, with denufosol tetrasodium for the treatment of cystic fibrosis.

Tags: , , , , , , ,
Posted in Financial Stocks, Health Care Stocks | No Comments »

ACLS excels, MSFT gains, THLD throttled

Thursday, December 16th, 2010

Axcelis Technologies Inc. (NasdaqGS: ACLS) gained 12.91 percent in price Thursday to $3.41. Volume of 1,723,617 shares nearly doubled its full-day average.  The Mass-based ACLS announced that its IntegraTM ES plasma dry strip system has been selected as the process tool of record by one of the world’s largest semiconductor manufacturers.

Microsoft Corp. (NasdaqGS: MSFT) traded Thursday in 32,635,809 shares, or about half its full-day average. MSFT share prices gained 0.22 per cent, to $27.90. Microsofts’s board of directors Wednesday declared a quarterly dividend of $0.16 per share.

Threshold Pharmaceuticals Inc. (NasdaqCM: THLD) lost 10.61 percent Thursday to $1.18. Volume of 236,558 shares more than tripled its full day average. The California-based THLD is a biotechnology company focused on the discovery and development of drugs targeting Tumor Hypoxia, the low oxygen condition found in microenvironments of most solid tumors.

Tags: , , , , , ,
Posted in Health Care Stocks, Industrial Stocks, Technology Stocks | No Comments »

THLD jumps, BAC active, SYX slumps

Wednesday, December 15th, 2010

Threshold Pharmaceuticals Inc. (NasdaqCM: THLD) vaulted 21.05 percent Wednesday noon to $1.38. Volume of 1,028,078 left its full-day average of 34, 640 in the dust. THLD, based in Redwood City, Calif., is a biotechnology company focused on the discovery and development of drugs targeting Tumor Hypoxia, the low oxygen condition found in microenvironments of most solid tumors.

Bank of America Corp. (NYSE: BAC) was among the volume leaders Wednesday noon, trading in 57,485,230 shares, nearing its full-day average of 210,883,000. Share prices improved 0.7 per cent, to $12.48. U.S. equities are the primary beneficiary of the continuing upswing in global investor sentiment, according to the BofA Merrill Lynch Survey of Fund Managers for December. A net 44 percent of the respondents predict the world’s economy to strengthen in 2011, compared to 35 percent a month earlier.

SYSTEMAX INC. (NYSE: SYX) ) fell 4.96 percent in Wednesday morning trading to $12.45. Volume of 116,067 shares better than doubled its full-day average. The Company sells personal computers, computer components and supplies, consumer electronics and industrial products

Tags: , , , , , , ,
Posted in Financial Stocks, Technology Stocks | No Comments »